// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1671 Abstracts

Identification of resistance mutations to crizotinib through circulating tumor cell (CTC) analysis in ALK-rearranged non-small-cell lung cancer (NSCLC)

Emma Pailler - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Crizotinib

DNA methylation analysis in liquid biopsy: A detailed study on quality control, sample storage and whole genome amplification procedures for downstream applications

Sofia Mastoraki - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A workflow to evaluate PD-L1 protein expression on circulating tumor cells (CTCs) from non-small cell lung cancer (NSCLC)

Corinne Renier - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

A novel assay for rapid identification and isolation of single intact circulating tumor cells

Lili Huang - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Selective targeting of circulating tumor cells with agonistic EphA2 ligand

Ahmed F. Salem - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Paclitaxel

A new mouse model of gastric adenocarcinoma: A valuable tool for preclinical studies

Jacob Till - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

PD0325901

AKT-ERK axis in circulating tumor cells is a target for metastatic suppression

Hung-Chi Cheng - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Pterostilbene

First-line doublet chemotherapy for mTNBC: circulating tumor cell analysis of the tnAcity trial

Minetta C. Liu - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Modeling selectin-coated microprobe adhesion to selectin ligands heterogeneously expressed on cancer tissues

Eric Martin - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArrayTM-HER2 FISH workflow

Lisa Koenig - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

The genetic heterogeneity and the molecular evolution of systemic metastatic castration resistant prostate cancer during therapy

Rui PL Neves - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment

Sofia Mastoraki - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Everolimus

Combination of a label independent CTC enrichment platform with fluorescence in situ hybridization for the molecular characterization of CTCs in non-small cell lung cancer patients

Aliki Ntzifa - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Tagrisso

Development of multi-marker capture and analysis of circulating tumor cells in renal cell carcinoma

Rory M. Bade - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Combined analysis of circulating tumor cells, fecal occult blood test and serum carcinoembryonic antigen for early detection and monitoring recurrence of patients with colorectal cancer

Wei-Shan Hung - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

High-definition single-cell analysis of liquid and solid biopsies reveals heterogeneity of circulating tumor cells in metastatic colorectal cancer

Anna S. Gerdtsson - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Expression of PD-L1 on circulating breast cancer cells: Correlation with clinicopathologic data and impact on prognosis

William Jacot - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Prognostic association of plasma cell free DNA (cfDNA) copy number variation based algorithmic score with survival in metastatic castration resistant prostate cancer (mCRPC)

Manish Kohli - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

CB-7598

The VAR2CSA malaria protein efficiently retrieves CTCs from a broad spectrum of cancers

Mette . Agerbk - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

A comprehensive assessment of the impact of preanalytical variables on cell free DNA and circulating tumor cells in blood

Anita Pottekat - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved